AR195805A1 - Procedimiento para la preparacion de nuevas penicilinas - Google Patents

Procedimiento para la preparacion de nuevas penicilinas

Info

Publication number
AR195805A1
AR195805A1 AR244770A AR24477072A AR195805A1 AR 195805 A1 AR195805 A1 AR 195805A1 AR 244770 A AR244770 A AR 244770A AR 24477072 A AR24477072 A AR 24477072A AR 195805 A1 AR195805 A1 AR 195805A1
Authority
AR
Argentina
Prior art keywords
procedure
preparation
new penicillins
penicillins
new
Prior art date
Application number
AR244770A
Other languages
English (en)
Spanish (es)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of AR195805A1 publication Critical patent/AR195805A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06Anabolic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/38One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
AR244770A 1971-10-23 1972-10-23 Procedimiento para la preparacion de nuevas penicilinas AR195805A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2152967A DE2152967C3 (de) 1971-10-23 1971-10-23 Acylureidopenicilline

Publications (1)

Publication Number Publication Date
AR195805A1 true AR195805A1 (es) 1973-11-09

Family

ID=5823251

Family Applications (1)

Application Number Title Priority Date Filing Date
AR244770A AR195805A1 (es) 1971-10-23 1972-10-23 Procedimiento para la preparacion de nuevas penicilinas

Country Status (31)

Country Link
JP (2) JPS55391B2 (lt)
AR (1) AR195805A1 (lt)
AT (1) AT320152B (lt)
BE (1) BE790440A (lt)
BG (2) BG21609A3 (lt)
CA (1) CA1019323A (lt)
CH (1) CH579089A5 (lt)
CS (1) CS188883B2 (lt)
CY (1) CY947A (lt)
DD (1) DD106044B3 (lt)
DE (1) DE2152967C3 (lt)
DK (1) DK134992C (lt)
EG (1) EG10826A (lt)
ES (1) ES407851A1 (lt)
FI (1) FI56839C (lt)
FR (1) FR2157908B1 (lt)
GB (1) GB1392849A (lt)
HK (1) HK18578A (lt)
HU (1) HU167986B (lt)
IE (1) IE37123B1 (lt)
IL (1) IL40628A (lt)
KE (1) KE2824A (lt)
LU (1) LU66332A1 (lt)
NO (1) NO143909C (lt)
PH (1) PH9893A (lt)
PL (2) PL89056B1 (lt)
RO (2) RO63066A (lt)
SE (1) SE412236B (lt)
SU (1) SU527139A3 (lt)
YU (1) YU264072A (lt)
ZA (1) ZA727473B (lt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3972869A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
US4009272A (en) * 1971-10-23 1977-02-22 Bayer Aktiengesellschaft Penicillins
US3983105A (en) * 1971-10-23 1976-09-28 Bayer Aktiengesellschaft Penicillins
US3972870A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
US3978056A (en) * 1971-10-23 1976-08-31 Bayer Aktiengesellschaft Penicillins
US3974142A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
NL175419C (nl) * 1971-10-23 1984-11-01 Bayer Ag Werkwijze ter bereiding of vervaardiging van antibiotisch werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van antibiotisch werkzame alfa-gesubstitueerde 6-(alfa-(3-acylureido)acetylamino) penicillanzuurderivaten.
US3974141A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
DE2258973A1 (de) * 1972-12-01 1974-06-06 Bayer Ag Penicilline, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS587637B2 (ja) * 1973-12-27 1983-02-10 住友化学工業株式会社 シンキペニシリンノ セイホウ
DE2407715C2 (de) * 1974-02-18 1982-12-02 Bayer Ag, 5090 Leverkusen Cephalosporine, Verfahren zu ihrer Herstellung sowie Arzneimittel
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
DE2525541C2 (de) * 1975-06-07 1984-01-12 Bayer Ag, 5090 Leverkusen β-Lactam-Antibiotica, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
DE2810083A1 (de) 1978-03-08 1979-09-20 Bayer Ag Beta-lactam-verbindungen
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
EP1780213A1 (en) * 2005-10-27 2007-05-02 3M Innovative Properties Company Silicon-urea-azolides, their preparation and use in the preparation of silicones with isocyanate terminal groups
TWI417095B (zh) 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc 1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
CN101801930B (zh) 2007-09-14 2013-01-30 奥梅-杨森制药有限公司 1,3-二取代的-4-苯基-1h-吡啶-2-酮
JP5366269B2 (ja) 2007-09-14 2013-12-11 ジャンセン ファーマシューティカルズ, インコーポレイテッド. 1,3−二置換4−(アリル−x−フェニル)−1h−ピリジン−2−オン
US9114138B2 (en) 2007-09-14 2015-08-25 Janssen Pharmaceuticals, Inc. 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones
US8785486B2 (en) 2007-11-14 2014-07-22 Janssen Pharmaceuticals, Inc. Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
WO2010025890A1 (en) 2008-09-02 2010-03-11 Ortho-Mcneil-Janssen Pharmaceuticals, Inc 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
WO2010043396A1 (en) 2008-10-16 2010-04-22 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
WO2010060589A1 (en) 2008-11-28 2010-06-03 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
MX2011011962A (es) 2009-05-12 2012-02-28 Janssen Pharmaceuticals Inc Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostericos positivos de receptores de glutamato metabotropico (mglur2).
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
SG10201402250TA (en) 2009-05-12 2014-07-30 Janssen Pharmaceuticals Inc 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
BRPI1012905A8 (pt) * 2009-06-10 2018-01-02 Yu Chongxi composições ou profármacos de elevada penetração dos compostos antimicrobianos e relacionados com antimicrobianos
ES2552879T3 (es) 2010-11-08 2015-12-02 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
EP2643320B1 (en) 2010-11-08 2015-03-04 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
WO2012062750A1 (en) 2010-11-08 2012-05-18 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
EA201891617A3 (ru) 2014-01-21 2019-04-30 Янссен Фармацевтика Нв Комбинации, содержащие положительные аллостерические модуляторы или ортостерические агонисты метаботропного глутаматергического рецептора 2 подтипа, и их применение
HUE053734T2 (hu) 2014-01-21 2021-07-28 Janssen Pharmaceutica Nv 2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait tartalmazó kombinációk és alkalmazásuk

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1770620A1 (de) * 1968-06-12 1971-11-11 Bayer Ag Neue Penicilline

Also Published As

Publication number Publication date
PH9893A (en) 1976-06-08
BG21609A3 (lt) 1976-07-20
DK134992C (da) 1977-07-18
RO60670A (lt) 1976-10-15
JPS57843B2 (lt) 1982-01-08
CY947A (en) 1978-06-23
DE2152967B2 (de) 1981-02-19
CA1019323A (en) 1977-10-18
CS188883B2 (en) 1979-03-30
YU264072A (en) 1982-06-18
BE790440A (lt) 1973-04-24
JPS4849787A (lt) 1973-07-13
IL40628A (en) 1976-08-31
LU66332A1 (lt) 1973-01-23
DK134992B (da) 1977-02-21
JPS4849910A (lt) 1973-07-14
JPS55391B2 (lt) 1980-01-08
AU4806472A (en) 1974-04-26
NO143909C (no) 1981-05-06
BG20813A3 (lt) 1975-12-20
IE37123B1 (en) 1977-05-11
PL93574B1 (lt) 1977-06-30
FR2157908A1 (lt) 1973-06-08
ZA727473B (en) 1973-07-25
HK18578A (en) 1978-04-14
NO143909B (no) 1981-01-26
IL40628A0 (en) 1972-12-29
DD106044A5 (lt) 1974-05-20
RO63066A (fr) 1978-06-15
IE37123L (en) 1973-04-23
FI56839B (fi) 1979-12-31
HU167986B (lt) 1976-02-28
AT320152B (de) 1975-01-27
PL89056B1 (lt) 1976-10-30
DE2152967A1 (de) 1973-05-03
FR2157908B1 (lt) 1976-03-19
GB1392849A (en) 1975-04-30
FI56839C (fi) 1980-04-10
ES407851A1 (es) 1975-10-01
DD106044B3 (de) 1990-07-18
EG10826A (en) 1976-12-31
SU527139A3 (ru) 1976-08-30
KE2824A (en) 1978-04-07
SE412236B (sv) 1980-02-25
CH579089A5 (lt) 1976-08-31
DE2152967C3 (de) 1981-11-19

Similar Documents

Publication Publication Date Title
AR195805A1 (es) Procedimiento para la preparacion de nuevas penicilinas
AR198787A1 (es) Procedimiento para la preparacion de nuevos derivados de indol
AR196634A1 (es) Procedimiento para la produccion de nuevas penicilinas
AR193426A1 (es) Procedimiento para la preparacion de derivados 7-amino sustituidos-desacetoxicefalosporanicos
MX4162E (es) Procedimiento para la preparacion de 3-metil cefalosporina
AR200002A1 (es) Procedimiento para la preparacion de sulfonamidas
AR199879A1 (es) Procedimiento para la elaboracion de 4-aza-benzimidazoles
AR197310A1 (es) Procedimiento para la produccion de hetacefalexina
AR203002A1 (es) Procedimiento para la preparacion de derivados de tetrahidrodibenzo-imidazo-azepinas
AR192612A1 (es) Procedimiento para la produccion de nuevos derivados de diazepina
AR204899A1 (es) Procedimiento para la preparacion de 3-carbamoiloximetilcefalosporinas
AR198178A1 (es) Procedimiento para la fabricacion de compuestos de de tetramisol
AR194603A1 (es) Procedimiento para la produccion de nuevos derivados de diazepina
AR202453A1 (es) Procedimiento para la preparacion de 3-alquiltiometil-7-acilamido cefalosporina
AR192970A1 (es) Procedimiento para la preparacion de derivados de guanidinofenilurea
AR203017A1 (es) Procedimiento para la preparacion de fenilimidazolidinonas
AR196408A1 (es) Procedimiento para la preparacion de derivados de tienodiazepina
AR192655A1 (es) Procedimiento para la preparacion de derivados de benzodiacepina
AR193576A1 (es) Procedimiento para la preparacion de pirimidotriacinas
AR196628A1 (es) Procedimiento para la preparacion de penicilinas
AR209254A1 (es) Procedimiento para la preparacion de derivados de fenil-bencilcetona
AR199892A1 (es) Procedimiento para la preparacion de esteres alquilicos de acido-metilquinoseolin-1,4-n-dioxido-2-carboxilico
AR197049A1 (es) Procedimiento para la preparacion de sulfonilaminopirimidinas
AR194991A1 (es) Procedimiento para la produccion de nuevos derivados de diazepina
AR194257A1 (es) Procedimiento para la preparacion de 3beta-hidroxi-14,15beta-epoxi-5-beta-cardenoli-o 5-beta-bufadienolid-glicosidos